Inovio Pharmaceuticals Inc (NASDAQ:INO)
| 0.82 Delayed Data As of Mar 31 |  +0.0278 / +3.51%Today’s Change | 0.78 Today|||52-Week Range 4.00 | -47.44% Year-to-Date |
Latest INO News | Press Releases
No recent news for Inovio Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.79 |
| Today’s open | 0.80 |
| Day’s range | 0.79 - 0.84 |
| Volume | 170,829 |
| Average volume (3 months) | 4,788,542 |
| Market cap | $253.9M |
Data as of 4:00pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | +19.36% |
| Earnings growth (this year) | +54.36% |
| Earnings growth (next 5 years) | +41.52% |
| Revenue growth (last year) | +478.23% |
| P/E ratio | NM |
| Price/Sales | 36.27 |
| Price/Book | 1.11 |
Competitors
Data as of 3:57pm ET, 03/31/2023
Financials
| Next reporting date | May 10, 2023 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $10.3M |
| Annual profit (last year) | -$279.8M |
| Net profit margin | -2,726.67% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Plymouth Meeting, Pennsylvania |
Forecasts
